Skip to main content
Premium Trial:

Request an Annual Quote

Genedrive, FIND Partner on HCV Assay Evaluation Study

NEW YORK (GenomeWeb) – Genedrive announced today that it has partnered with the Foundation for Innovative New Diagnostics (FIND) to begin a study to evaluate the firm's hepatitis C Virus ID Kit.

Genedrive's HCV ID Kit runs on the firm's portable molecular diagnostics platform and is designed for use in low-resource settings, delivering results in 90 minutes. The platform uses PCR amplification and melt curve analysis to rapidly amplify and detect target nucleic acid sequences without the need for nucleic acid isolation.

As part of the agreement, FIND will lead evaluation studies on the firm's assays in Cameroon and Georgia between September 2018 and May 2019. The studies are designed to confirm the assay's accuracy across a variety of genotypes, as well as to assess "usability in the intended market setting," the firm said.

In addition, Genedrive will provide product in-kind to support the study.

"Positive outcomes should further facilitate our commercialization activities in these regions, as well as provid[e] important clinical field data that others look to as they decide to implement Genedrive in their own specific settings," Genedrive CEO David Budd said in a statement.

FIND will integrate the evaluations of the firm's kit as part of its wider HCV diagnostics efforts. The group is the lead partner on a multi-year, multi-country project funded by Unitaid to advance development of simple HCV diagnostic tools.

Earlier this week, FIND signed a memorandum of understanding with Clinical Research Malaysia to develop a new strategy to diagnose HCV in decentralized primary healthcare facilities. Last month, FIND awarded grants to several firms to develop new HCV diagnostics, as well.   

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.